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Abstract
Background: Length of hospital stay (LOS) is a surrogate marker for patients' well-being during hospital treatment and 
is associated with health care costs. Identifying pretreatment factors associated with LOS in surgical patients may 
enable early intervention in order to reduce postoperative LOS.
Methods: This cohort study enrolled 157 patients with suspected or proven gynecological cancer at a tertiary cancer 
centre (2004-2006). Before commencing treatment, the scored Patient Generated - Subjective Global Assessment (PG-
SGA) measuring nutritional status and the Functional Assessment of Cancer Therapy-General (FACT-G) scale measuring 
quality of life (QOL) were completed. Clinical and demographic patient characteristics were prospectively obtained. 
Patients were grouped into those with prolonged LOS if their hospital stay was greater than the median LOS and those 
with average or below average LOS.
Results: Patients' mean age was 58 years (SD 14 years). Preoperatively, 81 (52%) patients presented with suspected 
benign disease/pelvic mass, 23 (15%) with suspected advanced ovarian cancer, 36 (23%) patients with suspected 
endometrial and 17 (11%) with cervical cancer, respectively. In univariate models prolonged LOS was associated with 
low serum albumin or hemoglobin, malnutrition (PG-SGA score and PG-SGA group B or C), low pretreatment FACT-G 
score, and suspected diagnosis of cancer. In multivariable models, PG-SGA group B or C, FACT-G score and suspected 
diagnosis of advanced ovarian cancer independently predicted LOS.
Conclusions: Malnutrition, low quality of life scores and being diagnosed with advanced ovarian cancer are the major 
determinants of prolonged LOS amongst gynecological cancer patients. Interventions addressing malnutrition and 
poor QOL may decrease LOS in gynecological cancer patients.
Background
Despite significant advances in cancer therapy, in-patient
hospital care remains a major expense in the treatment of
patients with gynecological cancer. Reducing length of
hospital stay (LOS) has the potential to decrease health
care cost, risk of infections and other hospital acquired
diseases, and to improve patients' quality of life (QOL).
Previous studies have observed differential LOS by can-
cer type and stage, however, these characteristics com-
monly are not available before surgery, and thus are not
amenable to pre-treatment interventions. Identifying
modifiable risk factors at admission predicting (LOS)
could lead to appropriately targeted interventions to
improve the delivery of care for women with gynecologi-
cal cancer. Previous research has shown that preoperative
serum albumin (a marker of chronic malnutrition),
hemoglobin and lymphocyte status are associated with
LOS and mortality in the gynecological oncology setting
[1-4]. Preoperative medical conditions or co-morbidities
could also be associated with LOS; however findings
regarding these predictors are inconsistent [4,5].
Acute malnutrition may be a further potentially amena-
ble risk factor for LOS. Malnutrition has been found to be
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associated with increased risk of morbidity and mortality,
complication rates such as wound infections, costs of
hospitalisation, and decreased QOL in various cancer
populations [2,4,6-16]. The scored Patient Generated -
Subjective Global Assessment (PG-SGA) is a validated
nutritional assessment tool specifically designed for can-
cer patients. Using the PG-SGA, we have observed high
levels of nutritional deficiencies among patients with
gynecological cancer, especially those diagnosed with
ovarian cancer [17,18], but to date no study has assessed
whether the scored PG-SGA can predict prolonged LOS
among gynecological cancer patients.
Gynecological cancer and/or malnutrition can have a
profound impact on patients' physical function and psy-
chosocial well-being - both important components of
QOL. One common definition of QOL is that it is a sub-
jective, multidimensional construct representing func-
tional status, mental and social well-being as well as
general health [19]. Health-related QOL before treatment
commences has been suggested as an important prognos-
tic factor in ovarian cancer patients [20,21]. To our
knowledge, no study to date evaluated the association
between preoperative QOL, malnutrition and LOS
among a wider range of gynecological cancer patients.
Thus, the purpose of this study was to evaluate factors
available prior to initial treatment to predict LOS in
patients with suspected or proven gynecological cancer.
Methods
The study was conducted at the Queensland Centre for
Gynecological Cancer at the Royal Brisbane and
Women's Hospital, Brisbane, Australia. Patients with pre-
sumed or proven primary gynecological cancer were
screened for eligibility at their preoperative visit between
March 2004 and December 2006. Patients were excluded
from the study if they presented with recurrent cancer,
had received treatment for other cancers within the past
five years, had psychological or cognitive impairments
(e.g. schizophrenia, dementia) or were non-English
speaking. A total of 194 patients gave informed written
consent. Thirty-two study participants declined to com-
plete the Functional Assessment of Cancer Therapy-Gen-
eral (FACT-G) questionnaire and five participants had to
be excluded from analyses due to incomplete data. Over-
all, 157 women completed both the scored PG-SGA and
the FACT-G questionnaire before commencing treat-
ment. Patients' clinical and demographic characteristics
including age at study entry, body mass index, serum
albumin, hemoglobin, lymphocytes, co-morbidities,
adverse events, surgical approach, LOS, and histopatho-
logical diagnosis and staging according to the Interna-
tional Federation of Gynecology and Obstetrics (FIGO)
were recorded prospectively. Six women did not undergo
surgery, because a surgical approach was contraindicated
or chemotherapy and/or radiotherapy was initiated as the
primary treatment. Pre-treatment serum albumin levels
were recorded in 146 patients; hemoglobin and lympho-
cyte count in 153 patients and actual body weight and
height for all but one patient. All pre-treatment predic-
tive factors were collected either at the outpatient or pre-
admission clinic, typically one to five weeks before
primary treatment was initiated. The median waiting
time for surgery was two weeks for women with sus-
pected ovarian and cervical cancers and five weeks for
women with suspected benign diseases or endometrial
cancer, respectively. Women were categorised according
to their clinical diagnosis before surgery: pelvic mass/
benign disease, suspected advanced ovarian cancer, cer-
vical cancer or endometrial cancer. This study has been
approved by The Royal Brisbane and Women's Hospital
Human Research Ethics Committee (Protocol Number
2004/007) and the University of Queensland Medical
Research Ethics Committee (Brisbane, Australia; Project
Number 2006000533).
Nutritional assessment
The scored PG-SGA is a validated nutritional assessment
tool for cancer patients [9,16] that records and summa-
rizes weight changes, alterations in food intake, gastroin-
testinal symptoms (such as nausea, vomiting and
diarrhoea that have persisted for two weeks), and changes
in functional capacity and physical signs of malnutrition.
These signs were assessed by a trained clinical dietician
using skinfold measurements (loss of subcutaneous fat,
muscle wasting, edema). The presence of ascites was
established radiologically and abstracted from the clinical
notes for this study. Based on the global rating, women
were classified as well nourished (PG-SGA A); moder-
ately malnourished or suspected of being malnourished
(PG-SGA B); or severely malnourished (PG-SGA C). The
PG-SGA also incorporates a numerical score (PG-SGA
score). Typical scores achieved by gynaecological cancer
patients range from 0-28 [22], with higher scores reflect-
ing greater risk of malnutrition. Scores of nine or more
indicate a critical need for nutritional intervention
options and/or improved symptom management [23].
QOL assessment
QOL was measured by the FACT-G questionnaire, which
is a widely utilized and validated instrument [24]. Version
4 of the FACT-G is a 27-item self-report measure and
allows patients to rate their current physical (7 items,
range: 0-28), social and family (7 items, range: 0-28),
emotional (6 items, range: 0-24), and functional well-
being (7 items, range: 0-28). The FACT-G is scored using
a 5-point scale (0 = not at all, 1 = a little bit, 2 = some-
what, 3 = quite a bit, 4 = very much). The raw scores wereLaky et al. BMC Cancer 2010, 10:232
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are linearly transformed as per questionnaire manual
with higher scores indicating better QOL [25].
Statistical analysis
Descriptive statistics were used to summarize patient
characteristics and to group patients by the main out-
come variable (average versus prolonged LOS). Pro-
longed LOS was defined as LOS of greater than five days
for patients who underwent open abdominal surgery and
greater than two days for patients who underwent vaginal
of laparoscopic surgery. Univariate logistic regression
analyses were conducted to calculate odds ratios adjusted
for age and surgical approach for patients who had pro-
longed compared to average LOS.
Variables significantly associated with LOS were then
entered into a multivariable model (Table 1).
All models were adjusted for age and surgical approach
(open-abdominal, vaginal or laparoscopic surgery). Hos-
mer-Lemeshow goodness-of-fit statistic assessed fit of
the models. SPSS software version 16.0 Graduate Student
(SPSS Inc., Chicago, IL, USA) was used for the statistical
analyses.
Results
Patient Characteristics
Patients' mean age was 58 years (SD 14 years). Preopera-
tively, 81 (52%) patients presented with suspected benign
disease/pelvic mass, 23 (15%) were suspected to have
advanced ovarian cancer, 36 (23%) patients to have endo-
metrial cancer, and 17 (11%) patients to have cervical
cancer. Ninety-four patients were operated using an
open-abdominal, 40 patients with a laparoscopic and 17
patients with a vaginal surgical approach. Data on
patients' weight, body mass index, albumin and PG-SGA
have been reported in previous publications [17,22].
LOS and potential predictors
The median LOS for all patients in the study was 5 days
(range 0-43 days). In total, 75 (48.1%) of the patients had
prolonged LOS (Table 1). Patients with prolonged LOS
were significantly older (mean age 62.8 years, SD 13.7)
than patients with average LOS (mean age 54.5 years, SD
13.6) (p < 0.01).
BMI was not significantly associated with LOS.
Although fifty patients had two or more pre-existing
medical co-morbidities, neither the number (Table 1),
nor the specific type of co-morbidity (data not shown),
were significantly different between patients with average
and prolonged LOS. Low pretreatment serum albumin or
hemoglobin levels, low QOL FACT-G scores and high
PG-SGA scores were associated with prolonged LOS.
Compared to patients with a suspicious pelvic mass,
patients suspected to carry an advanced ovarian cancer
were significantly more likely to have prolonged LOS (OR
= 30.4; 95% CI = 3.9-236.7) (Table 1).
In the multivariable model, patients with good QOL
were at significantly lower risk for prolonger LOS (OR =
0.96, 95% CI 0.93-0.99; p = 0.007). Patients with PG-SGA
B or C (OR = 5.28, 95% CI = 0.98-28.5, p = 0.05) and
patients with suspected advanced stage ovarian cancer
(OR = 14.7, 95% CI = 1.61-134.7. p = 0.02) were signifi-
cantly more likely to have prolonger LOS compared to
other patients (Table 1).
Discussion
This study assessed factors predictive for prolonged LOS
(defined as >5 days or >2 days, for patients who had open
abdominal or laparoscopic surgery, respectively) among
gynecological cancer patients. Malnutrition and low
QOL were found to predict prolonged LOS independent
of patients' age at diagnosis, surgical approach (laparos-
copy or laparotomy), albumin and hemoglobin and sus-
pected clinical diagnosis. Patients suspected to have stage
III or IV ovarian cancer were also independently at
greater risk for prolonged LOS compared to other
patients.
Previous studies have shown that malnutrition was
associated with prolonged LOS in hospitalized patients
requiring treatment for various types of cancer [13,16,26-
28]. The present manuscript is the first to confirm those
findings for patients with gynecological cancer, and
extends these findings even further. The present data sug-
gest an association between pre-operative malnutrition
and LOS based on both the PG-SGA global rating and the
PG-SGA score. To our knowledge there is only one previ-
ous study which assessed the PG-SGA score (as opposed
to the global rating) and LOS [15]. Thomas and col-
leagues found a weak correlation between LOS and the
PG-SGA score [15], and similar in our study the PG-SGA
score was the weaker predictor compared to the global
rating in multivariable analysis. However, the PG-SGA
score provides dieticians with suggested appropriate
intervention strategies and thus can be a clinically useful
adjunct to the global rating.
Our findings show that LOS was not equally distributed
between tumor types. Even after adjustment for age and
surgical approach, 96% of all suspected advanced stage
ovarian cancer patients had prolonged hospital stay, com-
pared with only 50% of patients with endometrial cancer
and 42% of patients with a pelvic mass. In our previous
work we described in detail that malnutrition was almost
exclusively present in ovarian cancer patients compared
to other gynecologic oncology diagnoses [17].
A previous study by Dean and colleagues found that
gynecological cancer patients with two or more pre-exist-
ing co-morbidities had significantly longer LOS thanLaky et al. BMC Cancer 2010, 10:232
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those with one or no co-morbidities [5]. In contrast, our
findings suggest that in this sample of gynecological can-
cer patients, neither the number of co-morbidities nor
the type of co-morbidity are predictive of prolonged LOS.
Further studies are required to validate these findings,
carefully separating preoperative co-morbidities from
postoperative complications.
In this study, we found low preoperative hemoglobin
and lymphocyte counts in a small number of patients and
these patients were more likely to experience prolonged
LOS, but this difference was no longer statistically signifi-
cant in adjusted modelling. Previous studies suggested
that low hemoglobin levels were related to poor survival
in patients with ovarian cancer [29,30], and studies dif-
fered in their conclusions regarding the importance of
age, histology, nutritional status and immune system on
lymphocyte counts [31-33]. With our non-significant
Table 1: Pre-surgical factors associated with prolonged length of hospital stay (LOS).
% (n) with Univariate model1 Multivariable model2
N prolonged LOS OR 95% CI P OR 95% CI P
Total 157 48.1 (75)
Body mass index
Underweight (<18.5) 3 66.7 (2) 2.96 0.12 - 70.3 0.50
Normal (18.5-24.99) 39 46.2 (18) Reference group
Overweight (25.0-29.99) 47 44.7 (21) 0.91 0.36 - 2.30 0.84
Obese (≥ 30) 67 50.7 (34) 1.31 0.55 - 3.16 0.54
Pre-existing co-morbidity
No or 1 co-morbidity 107 45.8 (49) Reference group
2 or more co-morbidities 50 54.0 (27) 0.12 0.56 - 2.75 0.59
Blood
Albumin
Average (>35 g/L) 124 41.9 (52) Reference group
Below Average (≤ 35 g/L) 22 86.4 (19) 8.81 1.82 - 42.6 0.007 0.86 0.12 - 6.5 0.88
Hemoglobin
Average (>120 g/L) 117 42.7 (50) Reference group
Below Average (≤ 120 g/L) 36 69.4 (25) 3.21 1.31-7.68 0.01 2.11 0.65-6.86 0.21
Lymphocytes
Average (1.5-4.0 × 109/L) 109 44.0 (48) Reference group
Below Average (≤ 1.5 × 109/L) 44 64.4 (27) 1.46 0.66 - 3.22 0.35
FACT-G global score 157 [75.3 ± 16.9]4 0.95 0.93 - 0.98 <0.001 0.96 0.93 - 0.99 0.007
Nutritional assessment
PG-SGA score 157 [9.5 ± 6.6]4 1.13 1.05 - 1.22 0.001 0.94 0.84 - 1.06 0.33
PG-SGA A 118 39.3 (44) Reference group
PG-SGA B and C 39 82.1 (32) 6.89 2.48 - 19.2 <0.001 5.28 0.98 - 28.5 0.05
Histology and Stage
Benign/LMP/OvCa stage I or II4 81 42.0 (34) Reference group
OvCa stage III or IV 23 95.7 (22) 30.4 3.9-236.7 0.001 14.7 1.6-134.7 0.02
Endometrial cancer 36 50.0 (18) 1.38 0.63-3.04 0.42 1.71 0.67-4.34 0.07
Cervical cancer 22 11.8 (2) 0.18 0.04-0.86 0.03 0.10 0.01-0.71 0.84
1adjusted for age and surgical approach; 2 Multivariable model including albumin, FACT-G score, PG-SGA score and PG-SGA global rating; 
adjusted for age and surgical approach; 3 Continuous variables: mean ± standard deviation for group with average LOS; 4Continuous variables: 
mean ± standard deviation for group with prolonged LOS;
Abbreviations: LOS, Length of hospital stay; OR, Odds Ratio; CI, Confidence interval; PG-SGA, Patient-Generated Subjective Global Assessment; 
FACT-G, Functional Assessment of Cancer Therapy-General.Laky et al. BMC Cancer 2010, 10:232
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results, we suggest that neither of these markers are suit-
able factors to predict prolonged LOS.
A third biochemical marker assessed in the present
study was serum albumin, generally believed to indicate
the presence of chronic malnutrition. Previous studies
have demonstrated an association between low serum
albumin and increased postoperative complications
[6,34,35], as well as reductions in survival in ovarian can-
cer patients [36]. The results of our study confirmed pre-
vious findings by Massad and colleagues in which they
found an inverse correlation between serum albumin and
LOS among patients with gynecological cancer [4]. How-
ever, our current results demonstrated that when albu-
m i n  a n d  P G - S G A  g l o b a l  r a t i n g  [ 2 2 ]  w e r e  a s s e s s e d
concurrently, the PG-SGA was a stronger predictor of
LOS, and therefore more sensitive to detect malnutrition
in gynecological cancer patients.
Research conducted on QOL and nutritional status in
cancer patients indicates that nutritional support may
lead to better QOL [11,37,38]. To our knowledge few
investigations have examined the association between
patients' pre-treatment QOL and prolonged LOS, while
concurrently assessing malnutrition. One study by Rogers
and colleagues found a weak correlation between better
QOL and shorter LOS in oral and oropharyngeal cancer
patients [39]. In the present study we found that poor
QOL prior to initial treatment was associated with pro-
longed LOS, and this association remained significant
when adjusted for other variables. Our results suggest
that subsequent studies should assess the effect of pre-
surgical nutritional interventions, or interventions aimed
at improving QOL on LOS. A limitation of our study was
that data on nutritional status and QOL were only
assessed before commencement of initial treatment and
not at any time point afterwards. This additional infor-
mation would have been of interest to identify whether
changes in patients' PG-SGA score and global rating and
FACT-G score are more influential for LOS than pre-
treatment score alone. In addition, given the preponder-
ance of malnutrition among ovarian cancer patients, sub-
sequent studies should focus on this subgroup of
gynecological cancer patients. However, our study also
has some major strengths, including the availability of
pre-treatment assessments for all patients, and the high
participation rate among patients with gynecological can-
cer.
Conclusions
In conclusion, prolonged LOS was found to be associated
with low presurgical QOL and malnutrition. Strategies to
reduce LOS and improve patients' well-being during hos-
pital stay will need to address these potentially modifiable
factors, particularly among women with suspected
advanced ovarian cancer.
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